The current work revealed a significant downregulation of PI3K, AKT, mTOR, and GSK-3β mRNA levels in cancer cells treated with GLE and GNPs compared to the untreated group, with a significant downregulation in GNPs compared to its free counterpart. The gene discussed is GSK3B; the disease is cancer.